In the Beta Blocker Evaluation of Survival Trial (BEST), nearly 2300 patients with advanced heart failure were randomized to bucindolol vs. placebo with background therapy that consisted of ACE ...

The commonly prescribed medicine beta-blockers may fight the progression of triple-negative breast cancer, researchers have ...

Beta blockers are a family of medicines that are actually used in a variety of fields of medicine, including psychiatry. In fact they're most frequently used as medications to treat high blood ...

BEST Substudy: Beta1-adrenergic Receptor Polymorphisms and the Prediction of Clinical Response in the Beta-Blocker Evaluation of Survival Trial - Medscape - Sep 24, 2004.

Individuals with some forms of heart failure are treated with drugs that are known as beta-blockers because they target proteins known as beta-adrenergic receptors (beta-ARs). Now, a potential ...

Noradrenaline Improves Behavioral Contrast Sensitivity via the β-Adrenergic Receptor. PLOS ONE, 2016; 11 (12): e0168455 DOI: 10.1371/journal.pone.0168455 ...

Commonly known to prevent heart attacks and lower blood pressure, beta blockers may now have a whole other indication: to boost immunotherapy treatments for patients with cancer. A study, conducted at ...

This is to say that the beta-receptor blockers are not created all the same, and thus differ in chemical properties, lipidophilic structure and specificity for the beta-adrenergic receptor. 17 New ...

Because beta-adrenergic receptors are the target for beta blockers, that predicted that if someone happens to be on a beta blocker when they undergo HSCT, the engraftment would be delayed and they ...

Among the patients in the combined beta-blocker groups who had a response, there were increases over time in the amount of mRNA for β 2 -adrenergic–receptor, sarcoplasmic-reticulum calcium ...

Although beta-adrenergic–receptor antagonists reduce morbidity and mortality in patients with mild-to-moderate chronic heart failure, their effect on survival in patients with more advanced ...